First Reported Head-to-Head Study Showed BYETTA[R] (exenatide) Injection Provided Greater Reduction in Post-Meal Glucose Levels Than Januvia (sitagliptin) in Patients With Type 2 Diabetes Patients Taking BYETTA Also Reduced Food Intake

Patients Taking BYETTA Also Reduced Food Intake Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) and Eli Lilly and Company (NYSE: LLY) announced results from a randomized, double-blind, cross-over, four-week head-to-head study demonstrating [...]